Identification and management of familial hypercholesterolaemia: What does it mean to primary care?

British Journal of General Practice

Volumn 59, Issue 567, 2009, Pages

  Qureshi, Nadeem ^a   Humphries, Steve E ^b   Seed, Mary ^c   Rowlands, Philip ^d   Minhas, Rubin ^e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d Briar Bank Studios ^*  (United States)

^e Medway Primary Care Trust   (United Kingdom)

Author keywords

Familial hypercholesteroaemia; Family health; Medical genetics; Primary health care

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FETUS DISEASE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; NOTE; ORAL CONTRACEPTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE;

FAMILY HEALTH; FAMILY PRACTICE; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION;

EID: 70350281232     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp09X472674     Document Type: Note

References (16)

1. DeMott K, Nherera L, Humphries SE, et al. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2008.
2. Marks D, Thorogood M, Farrer M, Humphries SE. Census of clinics providing specialist lipid services in the United Kingdom. J Public Health Med 2004; 26(4): 353-354. (Pubitemid 40070451)
3. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003; 168(1): 1-14. (Pubitemid 36559596)
4. Betteridge DJ, Broome K, Durrington PN, et al. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 1999; 142(1): 105-112.
5. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008; 29(21): 2625-2633.
6. Neil HA, Hammond T, Huxley R, et al. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ 2000; 321(7254): 148. (Pubitemid 30447007)
7. National Institute for Health and Clinical Excellence. Familial hypercholesterolaemia. Identification and management of familial hypercholesterolaemia. London: NICE, 2009. http://www.nice.org.uk/CG71 (accessed 3 Sep 2009).
8. Qureshi N, Wilson B, Santaguida P, et al. Appendix B: Forms/guides and internet family history tools. Family history tools available on the internet. In: Qureshi N, Wilson B, Santaguida P, et al. Collection and use of cancer family history in primary care. http://www.ahrq.gov/downloads/pub/evidence/pdf/ famhistory/famhist.pdf (accessed 16 Jun 2009).
9. Gray J, Jaiyeola A, Whiting M, et al. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008; 94(6): 754-758. (Pubitemid 351744695)
10. Starr B, Hadfield SG, Hutten BA, et al. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med 2008; 46(6): 791-803. (Pubitemid 351821631)
11. Hollman G, Olsson AG, Ek AC. Disease knowledge and adherence to treatment in patients with familial hypercholesterolemia. J Cardiovasc Nurs 2006; 21(2): 103-108.
12. Edison R, Muenke M. Congenital anomalies following gestational statin exposure. Am J Hum Genet 2003; 73: 212.
13. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005; 90(7): 3863-3870.
14. Khader YS, Rice J, John L, Abueita O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 2003; 68(1): 11-17. (Pubitemid 37271985)
15. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352(14): 1425-1435. (Pubitemid 40471450)
16. Amundsen AL, Khoury J, Iversen PO, et al. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis 2006; 189(2): 451-457. (Pubitemid 44740297)